总检察长汤恩宣布与Mylan达成800万美元和解：涉嫌合谋抬高EpiPen价格
康涅狄格州总检察长威廉·汤恩（William Tong）10月22日宣布，已与制药公司Mylan达成800万美元和解，指控该公司涉嫌非法抬高过敏急救药EpiPen的价格，违反州反垄断法和消费者保护法。
这项和解由总检察长办公室、州消费者保护厅和州公共卫生厅联合宣布。根据州总检察长办公室官网10月22日发布的新闻稿，调查指控Mylan涉嫌参与合谋，人为抬高EpiPen价格，损害消费者利益。
EpiPen是严重过敏反应患者的救命药，其价格问题多年来在美国备受争议。此次800万美元和解是康涅狄格州针对药品价格操纵采取的又一执法行动。和解的具体条款及资金分配方案，总检察长办公室将在新闻稿全文中进一步说明。
Attorney General Tong Announces $8 Million Settlement With Mylan: Alleged Conspiracy to Raise EpiPen Prices
Connecticut Attorney General William Tong announced on October 22 that the state has reached an $8 million settlement with pharmaceutical company Mylan, alleging the company illegally raised the price of the allergy emergency medication EpiPen in violation of state antitrust and consumer protection laws.
The settlement was announced jointly by the Attorney General's Office, the state Department of Consumer Protection and the state Department of Public Health. According to a press release issued by the Attorney General's Office on October 22, the investigation alleged that Mylan participated in a conspiracy to artificially inflate EpiPen prices, harming consumers.
EpiPen is a lifesaving medication for patients with severe allergies, and its pricing has been controversial in the United States for years. The $8 million settlement is another Connecticut enforcement action targeting drug price manipulation. The Attorney General's Office will detail the settlement terms and how the funds will be distributed in the full press release.
来源：GSM·美国（原文链接）
图片来源：康涅狄格州议会大厦 / Connecticut State Capitol — Paul Danese, CC0, via Wikimedia Commons
